Matthew Culbert, MD (@culbert_md) 's Twitter Profile
Matthew Culbert, MD

@culbert_md

#RadOnc & Developer @QuadShotNews #ReRTCalc #RadOncTables #RadOncCalc #ROToolbox Tweets=own views

ID: 1270418646461014017

calendar_today09-06-2020 18:13:12

168 Tweet

744 Followers

315 Following

Matthew Culbert, MD (@culbert_md) 's Twitter Profile Photo

Please test out our app and share your feedback to help us improve! A big thank you to Radiation Oncology Institute-The ASTRO Foundation for their backing. Thrilled to present it at #ASTRO23. Let's make it the best together! 🌟

radoncreview_org (@radoncreview) 's Twitter Profile Photo

New #PENTEC data has been programmed into the #RadOncCalc app. #ALARA Female reproductive tract: pubmed.ncbi.nlm.nih.gov/37804257/ Testicular dysfunction: pubmed.ncbi.nlm.nih.gov/37791936/ #ayacsm #radonc #ReadThePapers

New #PENTEC data has been programmed into the #RadOncCalc app. #ALARA 

Female reproductive tract: pubmed.ncbi.nlm.nih.gov/37804257/
Testicular dysfunction: pubmed.ncbi.nlm.nih.gov/37791936/ 

#ayacsm #radonc #ReadThePapers
Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

Have you tried the all new #RadOnc Toolbox at rotoolbox.org? Redesigned & completely overhauled w/ Drs. Matthew Culbert, MD & Colton Ladbury, MD, it now includes updated ASTRO guidelines, revamped dose constraints, a contouring resources library & various calculators & nomograms.

Have you tried the all new #RadOnc Toolbox at rotoolbox.org? Redesigned &amp; completely overhauled w/ Drs. <a href="/culbert_md/">Matthew Culbert, MD</a> &amp; <a href="/ColtonLadbury/">Colton Ladbury, MD</a>, it now includes updated ASTRO guidelines, revamped dose constraints, a contouring resources library &amp; various calculators &amp; nomograms.
Colton Ladbury, MD (@coltonladbury) 's Twitter Profile Photo

In anticipation of the #radonc in-service moving earlier this year, the exitthetxit.com user interface has been upgraded. Please check it out, share, and let me know what augmentations might better help you prepare! ARRO ACROresident

In anticipation of the #radonc in-service moving earlier this year, the exitthetxit.com user interface has been upgraded. Please check it out, share, and let me know what augmentations might better help you prepare! <a href="/ARRO_org/">ARRO</a> <a href="/ACROresident/">ACROresident</a>
Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

The ROI #Toolbox was released only 2 months ago and more than 900 people are using the new app! All gifts received during #gRADitude will be matched up to $12k! Join our team and make your gift: bit.ly/GivetoROI

The ROI #Toolbox was released only 2 months ago and more than 900 people are using the new app!
All gifts received during #gRADitude will be matched up to $12k! Join our team and make your gift: bit.ly/GivetoROI
Nadeem Riaz (@xrtgenomics) 's Twitter Profile Photo

1/N Finally out!! -- 30Gy for HPV+OPC in Journal of Clinical Oncology – work by the Memorial Sloan Kettering Cancer Center Head and Neck team, led by Nancy Lee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc #hncsm ascopubs.org/doi/10.1200/JC…

RadOnc Tables (@radonctables) 's Twitter Profile Photo

Rad Onc Tables new features: Protocols. If a protocol pdf is available, it will be linked to in the reference section We look forward to when hopefully publication of the protocol as a supplement is required and ideally a DOI 🤞🏻 Please let us know if a link becomes broken

Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

Dose Constraints for Reirradiation: What Do We Know? 📌The seminar is now accessible! 📌Availability may range from 1 month to as long as 6 months. 📌Please sign up if you are to access these videos here: forms.office.com/pages/response… #radonc #reirradiation #ReRT #ReCARE #ReTECH

Dose Constraints for Reirradiation: What Do We Know?

📌The seminar is now accessible! 
📌Availability may range from 1 month to as long as 6 months.
📌Please sign up if you are to access these videos here:
forms.office.com/pages/response…

#radonc #reirradiation #ReRT #ReCARE #ReTECH
Laura Dover (@lauradovermd) 's Twitter Profile Photo

Takeaways after a weekend of thoughtful conversation: 1. Rad oncs can unite behind curbing greed of hospitals/PE 2. Virtual care could be a tool for this greed 3. Virtual care does not intrinsically compromise care (can enhance) 4. Virtual care is here to stay. Full stop.

UFRadOnc (@ufradonc) 's Twitter Profile Photo

We are so excited to welcome three incredible people to our Gator family. Congratulations Nicholas Gutsche, Melisa Pasli, and Rami Shaker. We can't wait to have you join us! 🐊☢️🎉 #Radonc #Match2024 #MatchDay2024 UF Health UF Health Cancer Center UF Health Proton Therapy

We are so excited to welcome three incredible people to our Gator family. Congratulations Nicholas Gutsche, Melisa Pasli, and Rami Shaker. We can't wait to have you join us! 🐊☢️🎉 #Radonc #Match2024 #MatchDay2024
<a href="/UFHealth/">UF Health</a>
<a href="/UFHealthCancer/">UF Health Cancer Center</a>
<a href="/UFProtonTherapy/">UF Health Proton Therapy</a>
Nicholas Zaorsky, MD MS (@nicholaszaorsky) 's Twitter Profile Photo

Causes of death among people living with metastatic cancer pubmed.ncbi.nlm.nih.gov/38374318/ nature.com/articles/s4146… via Nature Communications Webtool: tinyurl.com/met-mortality We built highly predictive models to help guide patient management and develop National Comprehensive Cancer Network (NCCN) guidelines.

Causes of death among people living with metastatic cancer

pubmed.ncbi.nlm.nih.gov/38374318/
nature.com/articles/s4146…
via <a href="/NatureComms/">Nature Communications</a> 
Webtool: tinyurl.com/met-mortality

We built highly predictive models to help guide patient management and develop <a href="/NCCN/">National Comprehensive Cancer Network (NCCN)</a> guidelines.
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

To all oncologists, It's vital to recognize: “Patients with resectable disease have better outcomes, and you can’t account for that without randomizing.” #hncsm This truth is universal across ALL disease sites! #blcsm #esocsm #hpbcsm #kcsm #lcsm #radonc #surgonc #ESTRO24

Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

The #RadOnc Toolbox got a glow up just in time for #ASTRO24! This comprehensive resource now includes AJCC Staging & easy access to eContour. Get it now! iOS: apps.apple.com/us/app/ro-tool… Android: play.google.com/store/apps/det… rotoolbox.org

The #RadOnc Toolbox got a glow up just in time for #ASTRO24! This comprehensive resource now includes AJCC Staging &amp; easy access to eContour. Get it now! 

iOS: apps.apple.com/us/app/ro-tool… 

Android: play.google.com/store/apps/det…

rotoolbox.org
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

🎉 Excited to share our latest work: RadOncCalc – A Mobile-Friendly Tool to Enhance Radiation Oncology Practice 📱⚛️ How does RadOncCalc help radiation oncologists save time and enhance patient care? Let’s break it down in this Tweetorial! practicalradonc.org/article/S1879-… 🧵👇

🎉 Excited to share our latest work: RadOncCalc – A Mobile-Friendly Tool to Enhance Radiation Oncology Practice 📱⚛️

How does RadOncCalc help radiation oncologists save time and enhance patient care? Let’s break it down in this Tweetorial! 

practicalradonc.org/article/S1879-…

🧵👇
Nicholas Zaorsky, MD MS (@nicholaszaorsky) 's Twitter Profile Photo

Beta version of our app to predict the site of primary cancer in the setting of metastatic cancer (e.g., based on imaging without biopsy): primarycancerpredictor.netlify.app The accuracy is ~85%. Full manuscript coming soon.

Beta version of our app to predict the site of primary cancer in the setting of metastatic cancer (e.g., based on imaging without biopsy):
primarycancerpredictor.netlify.app

The accuracy is ~85%.

Full manuscript coming soon.
Ramez Kouzy, MD (@rkouzymd) 's Twitter Profile Photo

Happy to share one of my side projects: TRAC - Trial Reasoning and Analysis Companion. A web app I developed for augmenting trial understanding and variable visualization with GPT-4o under the hood. #AITools